Final Trial Results Confirm Disappointment on CureVac Vaccine - The New York Times
- Final Trial Results Confirm Disappointment on CureVac Vaccine The New York Times
- CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result The Washington Post
- UPDATE 1-CureVac COVID-19 vaccine records only 48% efficacy in final trial readout Yahoo Finance
- What is CureVacs COVID-19 vaccine, and why it failed to cross 50% threshold in efficacy Firstpost
- Coronavirus digest: Curevac jab only 48% effective... Читать дальше...